Addiction Treatment Gap Statistics 2026: How Many Americans Need Treatment vs. How Many Actually Receive It

Every year, researchers ask the American public two questions: how many people need treatment for a substance use disorder, and how many actually get it? The distance between the answers is the treatment gap, one of the most quoted, and most misquoted, sets of numbers in addiction medicine.

This page compiles the current treatment gap statistics from primary federal sources, explains why the figures most websites still repeat are survey generations out of date, and adds what national coverage almost never includes: state-level numbers for New Hampshire and Massachusetts. Every statistic links to the government survey or peer-reviewed study it comes from, with the data year stated inline.

Key numbers at a glance

• 48.4 million Americans aged 12 or older (16.8 percent) had a substance use disorder in the past year, per the 2024 NSDUH annual national report (data year 2024, released July 2025).
• 52.6 million people (18.2 percent) needed substance use treatment in 2024 (2024 NSDUH).
• Only 10.2 million people received any substance use treatment in 2024, which is 3.5 percent of the population aged 12 or older (2024 NSDUH).
• 19.3 percent of the people who needed treatment received it; 80.7 percent, roughly 42.4 million people, did not (2024 NSDUH).
• Only 4.4 percent of adults with an untreated substance use disorder perceived a need for treatment in 2024 (2024 NSDUH).
• 75.5 percent of adults who did perceive a need said they thought they should handle it on their own, the top stated reason for not getting care (2024 NSDUH).
• Receipt rises with severity but never gets far: 6.4 percent of people with a mild disorder, 11.8 percent with a moderate one, and 27.9 percent with a severe one received treatment in 2024 (2024 NSDUH).
• 2.6 million people with a substance use disorder (5.4 percent) received treatment via telehealth in 2024 (2024 NSDUH).
• Only 17.0 percent of people with an opioid use disorder received medication for it in 2024, and just 2.5 percent of people with an alcohol use disorder did (2024 NSDUH).
• In New Hampshire, 82.1 percent of people who needed treatment did not receive it in 2024; in Massachusetts, 84.0 percent, versus 80.7 percent nationally (2023-2024 NSDUH state estimates, 2025).
• 69,147 predicted drug overdose deaths occurred in the 12 months ending January 2026, down from 110,751 in the 12 months ending January 2023 but still the equivalent of a mid-size town every year (CDC provisional data, accessed July 2026).
• The hopeful counterweight: 74.3 percent of U.S. adults who ever had a substance use problem, about 23.5 million people, consider themselves to be in recovery or recovered (2024 NSDUH).

How many Americans need addiction treatment?

The authoritative source is the National Survey on Drug Use and Health (NSDUH), SAMHSA's federal household survey of Americans aged 12 and older. The newest edition, covering calendar year 2024, was released in July 2025.

According to the 2024 NSDUH, 48.4 million people aged 12 or older, 16.8 percent of that population, met diagnostic criteria for at least one substance use disorder (SUD) in the past year. That total breaks down into 27.9 million people with an alcohol use disorder and 28.2 million with a drug use disorder; the groups overlap, because 7.7 million people (about 1 in 6 of those with any SUD) had both.

Severity matters for interpretation: 55.8 percent of those 48.4 million people had a mild disorder and 21.3 percent a severe one. A mild disorder is still a diagnosable medical condition, but it helps explain a finding we return to below: many people in this population do not experience themselves as needing treatment.

NSDUH then defines "needing substance use treatment" as having a past-year SUD or having received treatment during the year. By that definition, 52.6 million people aged 12 or older, 18.2 percent, needed substance use treatment in 2024. Need was highest among young adults aged 18 to 25, at 26.8 percent (9.3 million people), compared with 18.0 percent of adults 26 or older (40.8 million) and 9.3 percent of adolescents aged 12 to 17 (2.4 million).

How many people actually receive addiction treatment?

Against those 52.6 million people who needed treatment, the 2024 NSDUH counted 10.2 million people aged 12 or older who received any substance use treatment in the past year. That is 3.5 percent of the total population, and 19.3 percent of the people who needed it.

Stated as a gap: 80.7 percent of Americans who needed substance use treatment in 2024, roughly 42.4 million people, did not receive it.

The gap is not evenly distributed by age. Among people who needed treatment in 2024:

• 30.2 percent of adolescents aged 12 to 17 received it (732,000 people)
• 11.3 percent of young adults aged 18 to 25 received it (1.1 million people)
• 20.5 percent of adults aged 26 or older received it (8.4 million people)

Note the inversion: young adults have the highest rate of need of any age group (26.8 percent) and the lowest rate of treatment receipt (11.3 percent). No other demographic slice of the 2024 data captures the treatment gap as starkly as that pairing.

Severity helps, but not nearly enough. Among people with a past-year SUD in 2024, treatment receipt rose from 6.4 percent of those with a mild disorder to 11.8 percent with a moderate disorder and 27.9 percent with a severe disorder (2024 NSDUH). Even among the most severe cases, nearly three quarters received no treatment at all.

Why the famous "1 in 10" statistic is obsolete

For roughly a decade, the most repeated line in this topic was that "only 1 in 10 people with addiction receive treatment." The line has a real pedigree: the Surgeon General's 2016 report Facing Addiction in America stated that only 10.4 percent of individuals with a substance use disorder receive treatment, a fair summary of the surveys of that era. Pages still circulate figures like 20.8 million people with a substance use disorder and about 10 percent receiving treatment (that pair is from the 2015 survey), or 40.3 million people with SUD and 6.3 percent treated (a 2020-era figure), and even the most careful stats hubs still lead with the 2023 survey's 54.2 million needing treatment, which the 2024 release has since superseded. Some of those pages carry recent "last updated" stamps. The numbers underneath have not been updated, and more importantly, they cannot be honestly compared with anything current. Here is why.

NSDUH was fundamentally redesigned starting with the 2021 survey, as documented in SAMHSA's NSDUH methodology materials:

1. Diagnostic criteria changed. NSDUH assessed substance use disorders with DSM-IV criteria in 2019 and earlier, then switched to DSM-5 criteria beginning with the 2020 survey, as SAMHSA's trend-comparability FAQ documents. DSM-5 uses a single graded disorder (mild, moderate, severe) in place of the older abuse-versus-dependence split, which changes who counts as having an SUD.
2. Data collection changed. The 2021 through 2024 surveys used multimode collection (web plus in-person), where earlier surveys were in-person only. SAMHSA's own methodological conclusion, stated in the 2024 annual report, is that estimates from 2021 onward "are not comparable with estimates from 2020 or prior years."
3. The treatment questions themselves changed, twice. The substance use treatment questions were substantially revised for the 2022 survey (adding telehealth and clarifying medication treatment), and revised again in 2024 for inpatient and outpatient settings. SAMHSA states plainly in the 2024 report that, for treatment receipt, "4 years of data are not available to assess trends."

The practical consequence for anyone citing treatment gap statistics in 2026: the old "1 in 10" describes a different disorder definition and a much narrower definition of treatment, and even 2023-to-2024 treatment comparisons are invalid because the questions changed between those surveys. The only defensible current statement is the within-year 2024 pair, 19.3 percent of people who needed treatment received it and 80.7 percent did not. If you quote one number from this page, quote that pair, with the year attached.

The perception gap: most people who need treatment do not see it

The most striking finding in the 2024 data is not the size of the treatment gap. It is the reason for it.

Among people who had a past-year SUD in 2024 and did not receive treatment, the 2024 NSDUH found that only 4.4 percent of adults aged 18 or older perceived an unmet need for treatment. Among adolescents aged 12 to 17, the figure was 6.7 percent.

Read that again: more than 95 percent of adults with an untreated substance use disorder did not think they needed treatment. The treatment gap is, first and foremost, a perception gap. Cost, access, and stigma are real barriers, and the next section quantifies them, but they only come into play for the small minority who already believe they need help.

This is consistent with how addiction medicine understands the condition: as the National Institute on Drug Abuse describes, substance use disorders alter brain circuits involved in reward, stress, and self-control, and ambivalence about change is an expected clinical feature, not an anomaly.

"In a first assessment, it is rare that someone walks in convinced they need treatment. Ambivalence is part of the condition itself, not a character flaw. Our job is to meet people inside that ambivalence rather than wait for it to resolve on its own."

Dr. Richard Marasa, Medical Director, Clear Steps Recovery

Why people do not receive treatment: the reasons, ranked by the data

For adults who did perceive an unmet need, the 2024 NSDUH asked why they did not get treatment. This breakdown is published in the 2024 annual national report and its detailed tables (Table A.56B), and respondents could select multiple reasons. Among adults aged 18 or older with a past-year SUD and a perceived unmet need for treatment in 2024:

SAMHSA cautions that many of these percentages are statistically close together, so the precise ranking below the top items should not be over-read. Even so, the structure is clear: the three dominant reasons are readiness reasons, not resource reasons. The next tier mixes cost and insurance, stigma and privacy, and navigation, with nearly 4 in 10 adults saying they simply did not know how or where to get treatment.

"The barriers people name before treatment rarely survive the first month of it. Cost fears usually shrink once insurance is actually verified, and scheduling can be worked around. Readiness is the real work, and it is exactly why outpatient care is designed to let people start where they are, without putting the rest of their life on hold."

Dr. Richard Marasa, Medical Director, Clear Steps Recovery

What treatment people receive: levels of care and medication

The 2024 NSDUH also recorded where and how the 10.2 million people who received treatment got it. Types and locations are not mutually exclusive, since one person can use more than one. Among people aged 12 or older in 2024 (2024 NSDUH):

Outpatient care is by far the most common setting, reaching almost three times as many people as inpatient care. Of the 7.1 million people who received outpatient treatment, 86.2 percent got it somewhere other than a general medical clinic or doctor's office, typically a dedicated program such as an intensive outpatient program.

The medication numbers deserve their own line, because they measure a gap within the gap. Among the 27.9 million people with a past-year alcohol use disorder in 2024, only 2.5 percent (697,000 people) received medication for it. Among the 4.8 million people with a past-year opioid use disorder, 17.0 percent (818,000 people) received medication for opioid use disorder. Medication-assisted treatment is among the best-evidenced interventions in addiction medicine, as NIDA's treatment research overview summarizes, yet the 2024 data show that the overwhelming majority of people whose disorders these medications treat never receive them.

Telehealth and virtual care: the access route that is actually growing

Telehealth is the newest formally measured treatment route in NSDUH, and in 2024 it already reached 3.6 million people aged 12 or older (1.3 percent). Among people with a past-year SUD, 5.4 percent (2.6 million) received substance use treatment via telehealth in 2024, ranging from 3.6 percent of young adults to 6.0 percent of adults 26 or older (2024 NSDUH).

Does virtual treatment work? The peer-reviewed evidence to date says yes, for the right patients:

• A longitudinal study of 3,642 intensive outpatient patients (Gliske et al., JMIR Mental Health, 2022) found no significant difference in abstinence at 3-month follow-up between in-person, hybrid, and virtual-only IOP; 70.8 percent of follow-up respondents reported abstinence since discharge across all formats.
• A retrospective cohort of 4,724 telehealth IOP patients (Contreras-Schwartz et al., Healthcare, 2024) found nearly 80 percent still engaged at 30 days, above the 50 to 68 percent range the authors cite for conventional in-person IOP, with 91 percent achieving at least 30 consecutive days of abstinence during treatment.

For a plain-language look at how virtual intensive outpatient care works day to day, see our guide to virtual IOP.

"Virtual intensive outpatient care genuinely closes the distance for people who would otherwise never make it through the door, especially working adults and parents. When someone is medically unstable, or home is where the substance use lives, in-person care is still the right call. The format should follow the clinical picture, not the other way around."

Dr. Richard Marasa, Medical Director, Clear Steps Recovery

The treatment gap in New Hampshire and Massachusetts

National statistics hide state realities, and almost no one publishes citable state-level treatment gap numbers. The table below compiles them for New Hampshire and Massachusetts from SAMHSA's 2023-2024 NSDUH state prevalence estimates (released 2025; prevalence rows are 2023-2024 annual averages, treatment rows are 2024 annual estimates).

One honest caveat: state estimates carry wider uncertainty bands than national ones (SAMHSA publishes 95 percent credible intervals), so the pattern matters more than the decimals. And the pattern is consistent: both states show above-average SUD prevalence, Massachusetts notably so at 19.9 percent versus 16.9 percent nationally, alongside treatment receipt at or slightly below the national rate. Higher need plus equal-or-lower receipt equals a wider gap.

Deeper state data live with the state agencies: the New Hampshire DHHS substance misuse data hub and the Massachusetts Bureau of Substance Addiction Services statistics library publish admissions and outcomes data for their public treatment systems. For a practical local view, see our guide to finding addiction treatment in southern New Hampshire.

The veteran treatment gap

Veterans deserve their own line in any treatment gap analysis. According to the NSDUH data spotlight on veterans (2022-2024 annual averages), 17.5 percent of veterans who ever served in a military combat zone had a past-year substance use disorder, compared with 15.4 percent of veterans who did not serve in one, a difference the survey did not find statistically significant. Where combat-zone service showed clear, statistically significant differences was alcohol: 12.3 percent of combat zone veterans had a past-year alcohol use disorder versus 8.9 percent of other veterans, 24.8 percent reported past-month binge drinking versus 19.4 percent, and 8.7 percent reported heavy alcohol use versus 6.1 percent.

Veterans also have a dedicated access route that many families do not know about: community care referrals that let eligible veterans receive treatment from local providers. Our VA rehab program page explains how that pathway works in New Hampshire and Massachusetts.

Dual diagnosis and the gap

Co-occurring mental illness widens the treatment gap in both directions. In 2024, 21.2 million adults aged 18 or older had both any mental illness and a substance use disorder (2024 NSDUH). That is about one third of the 61.5 million adults with any mental illness and slightly under half of the 46.3 million adults with an SUD.

Among those 21.2 million adults with co-occurring conditions in 2024:

• 41.2 percent (8.8 million people) received no treatment for either condition
• 41.0 percent received mental health treatment only
• 3.2 percent received substance use treatment only
• Just 14.5 percent (3.1 million people) received both types of care, which is what clinical guidelines generally recommend

Even among the 6.9 million adults with serious mental illness plus an SUD, 29.9 percent received no treatment of any kind in 2024. The lesson: most people with co-occurring conditions who reach care get treated for the mental health condition while the substance use goes unaddressed.

Who falls into the gap: demographics of untreated addiction

The 2024 NSDUH detailed tables break down treatment receipt among people aged 12 or older with a past-year substance use disorder, and the pattern of who gets left behind is not what stereotype would predict. All figures are 2024 receipt rates among people with an SUD unless noted.

• By sex: essentially even. 12.1 percent of males and 12.5 percent of females with an SUD received treatment.
• By race and ethnicity: American Indian and Alaska Native people had the highest receipt rate (16.4 percent), followed by White (13.1 percent), multiracial (12.3 percent), and Black (12.0 percent) people. Hispanic or Latino people (10.5 percent) and especially Asian Americans (5.2 percent) were the least likely to receive treatment.
• By education (adults 18 or older): receipt falls as education rises, from 19.0 percent of adults without a high school diploma to 8.8 percent of college graduates.
• By employment (adults 18 or older): 9.3 percent of full-time workers with an SUD received treatment, versus 14.4 percent of unemployed adults, making working adults the largest untreated group in absolute numbers.
• By insurance (all people 12 or older): 7.4 percent of people covered by Medicaid or CHIP received substance use treatment in 2024, versus 2.7 percent with private insurance and 3.0 percent with no coverage. Receipt differences partly reflect who carries the heaviest need, but the insurance rows of the reasons table above show cost structure shaping who gets care.

What the treatment gap costs

The starkest consequence of untreated substance use disorder is death. CDC provisional data (Vital Statistics Rapid Release, accessed July 2026) put predicted drug overdose deaths at 69,147 for the 12 months ending January 2026. That is a historic improvement, down from 110,751 in the 12 months ending January 2023, a decline of roughly 38 percent, and the trend holds locally: Massachusetts fell from 2,704 to 1,324 and New Hampshire from 472 to 266 over the same window.

Two things are true at once: the overdose curve is finally bending downward, and nearly 70,000 deaths a year is still a catastrophe that overwhelmingly strikes people who were not in treatment. A system reaching only 19.3 percent of those who need it (2024 NSDUH) leaves the other 80.7 percent exposed to exactly this risk.

The counterweight belongs next to the cost, because it is what closing the gap buys. Among the 31.7 million U.S. adults who said in 2024 that they ever had a problem with their use of drugs or alcohol, 74.3 percent, about 23.5 million people, considered themselves to be in recovery or to have recovered (2024 NSDUH). Addiction is, as NIDA puts it, a treatable disorder, and the recovery statistics are the proof that the tens of millions inside the gap are not stuck there.

From barrier to answer: what actually closes the gap

The reasons table above is not just a diagnosis of the problem; it is a to-do list. Each major barrier in the 2024 data has an evidence-based answer.

• "Treatment costs too much" (45.3 percent) and insurance worries (32.4 and 25.7 percent). Most people overestimate out-of-pocket cost because their benefits have never been checked. Verification is free and fast; see how coverage works in New Hampshire and Massachusetts, and for people without coverage, our guide to who qualifies for free rehab explains the state-funded options.
• "Not ready to stop" (59.5 percent) and "should handle it on my own" (75.5 percent). Readiness is not a prerequisite for a conversation. Low-threshold outpatient care starts with an assessment and a few hours a week rather than an all-or-nothing commitment, and the evidence summarized by NIDA shows treatment works even when motivation is imperfect at the start.
• "No time" (41.3 percent) and logistics (19.8 percent). The barrier telehealth was built for: virtual IOP produces retention and abstinence outcomes comparable to in-person care in the studies above, on a schedule that fits around work and childcare.
• "Did not know how or where to get treatment" (38.9 percent). This one is solvable today. SAMHSA's confidential locator at FindTreatment.gov maps licensed programs nationwide, any provider's admissions team can walk you through options in a single call, and in a mental health crisis you can call or text 988.

Methodology and sourcing notes

All national prevalence, need, receipt, perception, reasons, level-of-care, medication, telehealth, demographic, and co-occurring figures come from the 2024 National Survey on Drug Use and Health annual national report and detailed tables (SAMHSA, July 2025), the most recent edition available. State figures come from SAMHSA's 2023-2024 NSDUH state estimates (prevalence rows are two-year averages; treatment rows are 2024-only, with 95 percent credible intervals). Veteran figures come from SAMHSA's veterans data spotlight (November 2025, pooled 2022-2024). Overdose figures are CDC Vital Statistics Rapid Release provisional counts accessed July 2026 and subject to revision. Telehealth outcomes come from the two peer-reviewed studies cited inline; the historical "1 in 10" figure is cited to its origin in the 2016 Surgeon General's report rather than repeated as current. Because NSDUH moved to DSM-5 criteria with the 2020 survey, to multimode collection in 2021, and revised its treatment questions in 2022 and 2024, no pre-redesign figure is presented as a trend point against current data, and every statistic is dated to its survey year. No statistic here comes from commercial or treatment-industry websites. The pull quotes from Dr. Marasa reflect clinical perspective, not statistical claims. This page is updated when SAMHSA or CDC release superseding data.

These numbers describe populations, not any individual's odds. For you or someone you love, the gap between needing help and getting it can close in a single phone call, and it does not require being certain of anything yet.